Pharm 101: Chlorpromazine

Class

First generation antipsychotic (FGA)


Pharmacodynamics
  • Aliphatic phenothiazine derivative
  • Greater blockade of D2 receptors than 5-HT-2a receptors (high D2/5-HT2A ratio)
  • Alpha1-receptor, M receptor and H1 receptor blockade (especially extensive alpha1 blockade, causing many autonomic adverse effects)
  • Clinical effects:
    • Low clinical potency
    • Medium extrapyramidal toxicity
    • High sedative action
    • High hypotensive action

Pharmacokinetics of antipsychotic drugs (general)
  • Characteristics of most antipsychotic drugs:
    • Readily but incompletely absorbed
    • Significant first-pass metabolism
    • Highly lipid soluble and protein bound (92-99%)
    • Large volumes of distribution (usually > 7L/kg)
    • Much longer duration of action than estimated from their plasma half-lives
    • Hepatic metabolism by oxidation or demethylation, catalysed by CYP450 enzymes

Clinical uses
  • Schizophrenia (alleviates positive symptoms)
  • Bipolar disorder (manic phase)
  • Antiemetic
  • Agitation

Adverse effects of antipsychotic drugs
  • Muscarinic cholinoceptor blockade:
    • Loss of accomodation, dry mouth, difficulty urinating, constipation
    • Tachycardia
    • Toxic-confusional state
  • Alpha-adrenoceptor blockade:
    • Postural hypotension
    • Impotence, failure to ejaculate
  • Dopamine-receptor blockade:
    • Parkinson’s syndrome
    • Akathisia, dystonias
    • Neuroleptic malignant syndrome
    • Amenorrhoea, galactorrhoea, infertility, impotence due to hyperprolactinaemia resulting from dopamine receptor blockade
  • Supersensitivity of dopamine receptors:
    • Tardive dyskinesia
  • H1 receptor blockade:
    • Sedation
  • Combined H1 and 5-HT2 blockade:
    • Weight gain
  • Specific to chlorpromazine:
    • Extensive alpha blockade causing hypotension
    • Seizures
    • Corneal deposits

Precautions/contraindications
  • Combination with other drugs producing extrapyramidal dysfunction, sedative effects, alpha-blockade, anti-cholinergic effects

Further reading

References

Pharm 101 700

Pharmacology 101

Top 200 drugs

MBBS (UWA) CCPU (RCE, Biliary, DVT, E-FAST, AAA) Emergency Medicine Advanced Trainee in Melbourne, Australia. Special interests in diagnostic and procedural ultrasound, medical education, and ECG interpretation. Editor-in-chief of the LITFL ECG Library. Twitter: @rob_buttner

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.